Evidence map›Paper›PMID 42533150›Full record

ArticleTheory in biosciences = Theorie in den Biowissenschaften2026

Optimal strategies for fair vaccine allocation: integrating non-pharmaceutical interventions, regional quarantine, and social challenges in epidemic control.

Fatemeh Mirsaeedi, Mohammad Sheikhalishahi, Mehrdad Mohammadi

Abstract read
PubMed Publisher
In one paragraph

Article in Theory in biosciences = Theorie in den Biowissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatemeh MirsaeediSchool of Industrial Engineering, College of Engineering, University of Tehran, Tehran, Iran.
Mohammad SheikhalishahiSchool of Industrial Engineering, College of Engineering, University of Tehran, Tehran, Iran. M.alishahi@ut.ac.ir.ORCID https://orcid.org/0000-0002-4134-9263
Mehrdad MohammadiDepartment of Industrial Engineering and Innovation Sciences, Eindhoven University of Technology, 5600MB, Eindhoven, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is essential to control epidemic diseases and adopt an optimal strategy when an epidemic occurs. In this research, a myopic model is presented. In this regard, an epidemic model is presented considering social challenges such as vaccine acceptance, quarantine of infected individuals, and regional quarantine. The vaccine allocation model was constructed to incorporate specific outputs from the epidemiological model, including (i) the weight of each cluster within each region, (ii) the vaccine demand of each cluster in each region, (iii) the relative infectiousness of region g, and (iv) the relative susceptibility of region g. By integrating these parameters, the allocation model determines equitable distribution strategies that aim to reduce the effective reproduction number. The model is run based on the data provided in similar articles, and its results are analyzed. By incorporating economic factors, like the costs of interventions, along with social factors such as individuals' willingness to get vaccinated, this model allows for an exploration of various aspects related to the fair allocation of vaccines. The rationality of the model's outcomes, supported by expert validation and reinforced through sensitivity analysis, underscores its accuracy and reliability.

Indexed as

EpidemicsQuarantineVaccinationVaccinesEpidemiological ModelsHumansModels, TheoreticalReproducibility of ResultsVaccinesEpidemiological modelFairnessRegional quarantineReproduction numberVaccine allocation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.